BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38330507)

  • 1. MHY1485 potentiates immunogenic cell death induction and anti-cancer immunity following irradiation.
    Sun L; Morikawa K; Sogo Y; Sugiura Y
    J Radiat Res; 2024 Mar; 65(2):205-214. PubMed ID: 38330507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHY1485 enhances X-irradiation-induced apoptosis and senescence in tumor cells.
    Sun L; Morikawa K; Sogo Y; Sugiura Y
    J Radiat Res; 2021 Sep; 62(5):782-792. PubMed ID: 34265852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin Enhanced Ionizing Radiation-Induced Immunogenic Cell Death in Glioma Cells through Endoplasmic Reticulum Stress Signaling Pathways.
    Xiu Z; Sun T; Yang Y; He Y; Yang S; Xue X; Yang W
    Oxid Med Cell Longev; 2022; 2022():5424411. PubMed ID: 36238646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic Reticulum-Targeting AIE Photosensitizers to Boost Immunogenic Cell Death for Immunotherapy of Bladder Carcinoma.
    Miao Z; Li J; Zeng S; Lv Y; Jia S; Ding D; Li W; Liu Q
    ACS Appl Mater Interfaces; 2024 Jan; 16(1):245-260. PubMed ID: 38113527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.
    Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H
    BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHY1485 promotes adriamycin sensitivity in HepG2 cells by inhibiting autophagy.
    Guo J; Lei Y; Liu L; Wen Z; Zhang B; Fang J; Liang G; Guo Q; Peng J
    Funct Integr Genomics; 2024 Feb; 24(1):22. PubMed ID: 38306005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marsdenia tenacissima extract induces endoplasmic reticulum stress-associated immunogenic cell death in non-small cell lung cancer cells through targeting AXL.
    Yuan Y; Guo Y; Guo ZW; Hao HF; Jiao YN; Deng XX; Han SY
    J Ethnopharmacol; 2023 Oct; 314():116620. PubMed ID: 37207882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy.
    Voloshin T; Kaynan N; Davidi S; Porat Y; Shteingauz A; Schneiderman RS; Zeevi E; Munster M; Blat R; Tempel Brami C; Cahal S; Itzhaki A; Giladi M; Kirson ED; Weinberg U; Kinzel A; Palti Y
    Cancer Immunol Immunother; 2020 Jul; 69(7):1191-1204. PubMed ID: 32144446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opaganib (ABC294640) Induces Immunogenic Tumor Cell Death and Enhances Checkpoint Antibody Therapy.
    Maines LW; Keller SN; Smith CD
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway.
    Wen H; Zhong Y; Yin Y; Qin K; Yang L; Li D; Yu W; Yang C; Deng Z; Hong K
    Int J Biol Sci; 2022; 18(7):2898-2913. PubMed ID: 35541893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of Dendritic Cells and Anti-PD-1 Antibody Converts X-ray Irradiated Tumors Into Effective In situ Vaccines.
    Wang Y; Zenkoh J; Gerelchuluun A; Sun L; Cai S; Li X; Tsuboi K
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):958-969. PubMed ID: 30458232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.
    Olivo Pimentel V; Marcus D; van der Wiel AM; Lieuwes NG; Biemans R; Lieverse RI; Neri D; Theys J; Yaromina A; Dubois LJ; Lambin P
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33688020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHY1485 activates mTOR and protects osteoblasts from dexamethasone.
    Zhao S; Chen C; Wang S; Ji F; Xie Y
    Biochem Biophys Res Commun; 2016 Dec; 481(3-4):212-218. PubMed ID: 27884298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor.
    Yuan S; Qiao T; Chen W
    Cancer Biother Radiopharm; 2011 Apr; 26(2):203-8. PubMed ID: 21539452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
    Wang L; Guan R; Xie L; Liao X; Xiong K; Rees TW; Chen Y; Ji L; Chao H
    Angew Chem Int Ed Engl; 2021 Feb; 60(9):4657-4665. PubMed ID: 33217194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models.
    Markovsky E; Budhu S; Samstein RM; Li H; Russell J; Zhang Z; Drill E; Bodden C; Chen Q; Powell SN; Merghoub T; Wolchok JD; Humm J; Deasy JO; Haimovitz-Friedman A
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):697-708. PubMed ID: 30342090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 3 signal augments radiation-induced tumor growth retardation in a murine model.
    Yoshida S; Shime H; Takeda Y; Nam JM; Takashima K; Matsumoto M; Shirato H; Kasahara M; Seya T
    Cancer Sci; 2018 Apr; 109(4):956-965. PubMed ID: 29465830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression of lysosomal fusion.
    Choi YJ; Park YJ; Park JY; Jeong HO; Kim DH; Ha YM; Kim JM; Song YM; Heo HS; Yu BP; Chun P; Moon HR; Chung HY
    PLoS One; 2012; 7(8):e43418. PubMed ID: 22927967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin induces immunogenic cells death and enhances therapeutic efficacy of checkpoint inhibitor in a model of murine lung carcinoma.
    Sun F; Cui L; Li T; Chen S; Song J; Li D
    J Recept Signal Transduct Res; 2019 Jun; 39(3):208-214. PubMed ID: 31441696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.